Cancer News
Oncologist Sentenced to 10 Years for Poisoning Colleague

The Value of Multiplex Genotyping for Lung Cancer

'Impressive' Duration of Response With Nivolumab in Melanoma

In NSCLC After Progression on First-line TKI, What Next?

'Unprecedented' Survival of 15 Months Seen in CLEOPATRA
What are the top 10 leading causes of death in the US?

Potent new cancer drugs likely with new protein 'map'

Survey reveals emotional exhaustion affects many cancer specialists

New estrogen-related breast cancer mechanism detected

Cancer during pregnancy: chemotherapy and radiotherapy are safe for babies, studies show
Scientists Detect Early Sign of Pancreatic Cancer

Increasing Skirt Sizes May Hike Your Breast Cancer Risk: Study

Lung Infections May Hamper Ability to Detect Lung Cancer

FDA Warns Doctors of Danger From Fake Drugs

Report Identifies Game Changers for U.S. Health Care
Melanoma Drug Combo Improves Patient Survival Rate, Decreases Risk of Harsh Side Effect

UCLA Scientists Discover Protein that Can Potentially Accelerate Recovery in Cancer Patients Following Radiation and Chemotherapy

Special Recognition for Jonsson Comprehensive Cancer Center at Avon Walk for Breast Cancer

FDA Approves Game-Changing Melanoma Drug that Turns on Immune System to Fight Deadly Cancers

Vault Nanoparticles Engineered at UCLA Show Promise for Cancer Treatment
Everolimus plus exemestane for hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer: Overall survival results from BOLERO-2

First FDA approval of neoadjuvant therapy for breast cancer: Pertuzumab for the treatment of patients with HER2-positive breast cancer

Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus

Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases